Vertex Pharmaceuticals
VRTX
#184
Rank
โ‚ฌ95.61 B
Marketcap
376,38ย โ‚ฌ
Share price
-4.56%
Change (1 day)
-15.97%
Change (1 year)

Earnings for Vertex Pharmaceuticals (VRTX)

Earnings in 2025 (TTM): โ‚ฌ4.01 Billion

According to Vertex Pharmaceuticals's latest financial reports the company's current earnings are โ‚ฌ12.00 Billion. , an increase over its 2024 earnings that were of โ‚ฌ0.24 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Vertex Pharmaceuticals from 1990 to 2025

Annual earnings

Year Earnings Change
2025 โ‚ฌ4.04 B1568.4%
2024 โ‚ฌ0.24 B-93.69%
2023 โ‚ฌ3.84 B3.19%
2022 โ‚ฌ3.72 B53.56%
2021 โ‚ฌ2.42 B-12.06%
2020 โ‚ฌ2.75 B118.45%
2019 โ‚ฌ1.26 B120.64%
2018 โ‚ฌ0.57 B1473.64%
2017 โ‚ฌ36.38 M197.6%
2016 โ‚ฌ12.22 M-102.97%
2015 -โ‚ฌ0.42 Billion-28.46%
2014 -โ‚ฌ0.58 Billion-51.5%
2013 -โ‚ฌ1.19 Billion-30584.68%
2012 โ‚ฌ3.89 M-95.47%
2011 โ‚ฌ85.95 M
2009 -โ‚ฌ0.52 Billion
2007 -โ‚ฌ0.36 Billion83.1%
2006 -โ‚ฌ0.2 Billion59.02%
2005 -โ‚ฌ0.13 Billion3.28%
2004 -โ‚ฌ0.12 Billion-38.16%
2003 -โ‚ฌ0.2 Billion
2000 -โ‚ฌ33.07 Million-20.38%
1999 -โ‚ฌ41.53 Million31.62%
1998 -โ‚ฌ31.55 Million91.05%
1997 -โ‚ฌ16.52 Million-36.24%
1996 -โ‚ฌ25.9 Million12.45%
1995 -โ‚ฌ23.04 Million27.4%
1994 -โ‚ฌ18.08 Million-1833.33%
1993 โ‚ฌ1.04 M-112.12%
1992 -โ‚ฌ8.61 Million175%
1991 -โ‚ฌ3.13 Million-12.2%
1990 -โ‚ฌ3.57 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
โ‚ฌ29.16 B 620.54%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
โ‚ฌ5.73 B 41.67%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
โ‚ฌ8.51 B 110.39%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
โ‚ฌ19.48 B 381.54%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
โ‚ฌ8.10 B 100.32%๐Ÿ‡บ๐Ÿ‡ธ USA
Enanta Pharmaceuticals
ENTA
-โ‚ฌ65.94 Million-101.63%๐Ÿ‡บ๐Ÿ‡ธ USA